Literature DB >> 16544936

A rapid and simple transcriptional sequencing method for GC-rich DNA regions.

Masaki Izawa1, Nobuo Kitamur, Nanae Odake, Fuminori Maki, Kaoru Kanehira, Hideyuki Nemoto, Mitsuyo Yamaguchi, Atsushi Yamashita, Nobuya Sasaki, Masahira Hattori, Shinji Kanayama, Yuko Yoned.   

Abstract

In genome sequencing project, we encounter the DNA regions that often contain stable secondary structure with high GC content. These regions are difficult to not only amplify by PCR for template preparations, but also determine the DNA sequences using standard Cycle sequencing (CS) method. Transcriptional sequencing (TS) is a unique DNA sequencing method using RNA polymerase, and is based on the principles of the chain-termination method, which is a powerful method to analyze GC-rich sequences. In this study, we examined the multiple displacement amplification (MDA) to overcome low efficiency of PCR amplification in GC-rich regions and subjected to TS reaction. Combination of MDA and TS (MDA-TS) was extremely successful with GC content ranging from 65% to 85%, which are difficult to analyze with PCR and CS. We also report plasmid vector, pTS1, which has the stronger T7 and T3 promoters than those of conventional vectors, and the sequence that decreases transcriptional efficiency was removed from its multiple cloning sites. pTS 1 resulted in the improved sequencing accuracy and reduced reaction time up to 5 min. These results showed that MDA-TS is a rapid and accurate method for the analysis of GC-rich templates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16544936

Source DB:  PubMed          Journal:  Jpn J Vet Res        ISSN: 0047-1917            Impact factor:   0.649


  1 in total

1.  Characterization of transcription from TATA-less promoters: identification of a new core promoter element XCPE2 and analysis of factor requirements.

Authors:  Ramakrishnan Anish; Mohammad B Hossain; Raymond H Jacobson; Shinako Takada
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.